Authors

Phage Therapy: Exploring the Future of Infection Treatment

Phage therapy, which uses lytic bacteriophages to target antibiotic-resistant bacteria, has resurfaced as a promising treatment for multidrug-resistant infections, but faces challenges in regulation, production, and clinical implementation despite its growing evidence of efficacy.

Specialty Pharmacy Technicians in Oncology Transitions of Care: An Untapped Workforce Resource

Specialty pharmacy technicians address barriers in oral anticancer therapy and transitions of care through improved care coordination and therapy access.

Medication Management and Supply Chain Still Underwater: Challenges and Future Trends in Health Care

The Fit Trap: Is Residency Selection Becoming a Popularity Contest?

Residency ranking often shifts from structured metrics to “fit” and vibes, risking bias toward familiarity; refocus decisions on evidence, values, and potential.

Evaluating Iron Sucrose Discordance: A Retrospective Health System Review

After transitioning iron sucrose 200 mg from an infusion to intravenous push, the incidence of discordance and infusion reactions were not statistically different.

Finerenone in HFmrEF and HFpEF: Findings from FINEARTS-HF

Finerenone consistently reduces heart failure events and cardiovascular death regardless of ischemic heart disease history, according to the FINEARTS-HF trial.

Connecticut Pharmacists Association Marks 150 Years of Advocacy, Innovation, and Service

This milestone celebration not only honors CPA’s legacy but also underscores the profession’s future—one defined by collaboration, innovation, and a steadfast commitment to patient care.

Half of Pharmacy Technicians Feel Fulfilled in Their Current Role

The Connecticut Society of Health-System Pharmacists Technician Committee survey explores the perception of career growth opportunities and challenges.

Connecticut Pharmacists Association Marks 150 Years of Advocacy, Innovation, and Service

This milestone celebration not only honors CPA’s legacy but also underscores the profession’s future—one defined by collaboration, innovation, and a steadfast commitment to patient care.

The FDA Approval of Keytruda Qlex: A Subcutaneous Version of Pembrolizumab

Keytruda Qlex is a subcutaneous formulation of pembrolizumab that offers a faster, more convenient alternative to IV administration with comparable efficacy.

MASLD Risk Factors Every Pharmacist Should Screen

From double-dipping GLP-1s to off-label pioglitazone, Cornell breaks down where the metabolic dysfunction-associated steatotic liver disease (MASLD) drug evidence stands today.

The Pharmacy Model Is Changing

Embracing artificial intelligence and other tools will be necessary to push the field forward.

The Evolving Fellowship Application Process

The process provides an opportunity for personal and professional growth.

Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases

The Pharmacist’s Role in MS Supplement Safety

In an interview with Pharmacy Times at the Consortium of Multiple Sclerosis Centers 2026, Julie Kidd, PhD, MPH, BCPS, the director of clinical services at Blue Ridge Neurology, presenting on Supplements in Multiple Sclerosis, discussed what the pharmacist's role in MS supplement safety.

Optimizing Infusion Chair Time for Oncology Trials: Follow-Up Study

This study evaluated factors affecting the duration of the infusion appointment times for 392 clinical trial patients.

What the Peptide Vote Actually Changes at My Counter (Hint: Not Much, Yet)

An FDA advisory vote boosts access hopes for peptide supporters, but compounding remains illegal pending rulemaking.

From Assessment to Discharge: Pharmacists Drive Safer, Patient-Centered Acute Pain Management

In an interview with Pharmacy Times, Brandon Kasberg, PharmD, discusses how pharmacists can help individualize multimodal acute pain regimens, reduce unnecessary opioid exposure, and support safer transitions from inpatient or postoperative care to the outpatient setting.

Afamitresgene autoleucel: The First T-Cell Receptor Therapy on the Market

Second-line and later treatment options for synovial sarcoma are limited. Afamitresgene autoleucel is the first FDA-approved T-cell receptor therapy, demonstrating long-lasting responses and tolerable adverse effects in pretreated patients.

Updated European MASLD Guidelines Review Prevention, Screening, and Treatments

Patients should be supported by a multidisciplinary team, frequent evaluations, and behavioral therapy for optimal care.

Vitamin C: Does Liposomal Formulation Make a Difference?

Oral liposomal vitamin C dietary supplementation demonstrates improved pharmacokinetics and pharmacodynamics, but a difference on immunity is inconclusive.

Deficiency in Care: Underutilization of Intravenous Iron for Acute Heart Failure

Ferric carboxymaltose is effective and guideline-endorsed, yet underutilized due to high cost and system-level barriers.

Is VER-01 a Turning Point for Cannabis-Derived Medicines?

In an interview with Pharmacy Times, Erin J. Walsh, PharmD, MS, RPh, MCST, discusses where VER-01 could fit in chronic pain management and why advances in standardized cannabinoid therapies may represent a pivotal moment for the future of evidence-based cannabis-derived medicines.

Levorphanol Safety and Clinical Practice: Risk Reduction, Workflow Impact, and the Pharmacist’s Role in Opioid Rotation

Pharmacy Times interviews Benjamin Kematick, PhD, BCACP, BCPMP, and explores the safety profile of Levorphanol compared with methadone, including potential reductions in risks such as accumulation, QT prolongation, and drug interactions, as well as its implications for clinical workflows and the pharmacist’s role in supporting safe opioid rotation, monitoring, and patient counseling.

Beat the Heat: 10 Common Medication Culprits Causing Heat Intolerance

Pharmacists can educate patients on preventive measures to avoid heat-related illnesses.

What the Removal of Black Box Warnings Means for Women, Hormone Therapies, and Pharmacists

Pharmacists guide women through updated menopause hormone therapy labels, rising demand, patch shortages, and personalized risk-benefit counseling.

Expert Q&A: Why COVID-19 Postexposure Prophylaxis Is a Pharmacist's New Tool

Jerry P. Abraham, MD, MPH, CMQ, discusses the persistent risks of COVID-19 and how a newly approved postexposure prophylaxis option is reshaping pharmacists' role in prevention.

Standardizing Supplement Recommendations in a Neuro-Oncology Clinic: A Pharmacist-Led Quality Improvement Initiative

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

How the PATINA Regimen Advances Maintenance Therapy for HR-Positive, HER2-Positive Metastatic Breast Cancer

Adding palbociclib to anti-HER2 and endocrine maintenance therapy provides a new treatment option for patients with HR-positive, HER2-positive metastatic breast cancer.

DPYD Testing Gains Ground: NCCN Guideline Update Reflects Decades of Work Toward Safer Chemotherapy